Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 10 | $49,509,779 |
Sells | 13 | $530,383 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
08 Jan 2024 18:23 | ZYME | Zymeworks Inc | GALBRAITH KENNETH | Chair & CEO | 08 Jan 2024 | Sale | 5,706 | 11.2156 | 63,996 | D |
08 Jan 2024 18:14 | ZYME | Zymeworks Inc | ASTLE CHRISTOPHER | SVP & Chief Financial Officer | 08 Jan 2024 | Sale | 1,431 | 11.2156 | 16,050 | D |
08 Jan 2024 18:01 | ZYME | Zymeworks Inc | MOORE PAUL ANDREW | Chief Scientific Officer | 08 Jan 2024 | Sale | 2,339 | 11.2156 | 26,233 | D |
08 Jan 2024 18:23 | ZYME | Zymeworks Inc | GALBRAITH KENNETH | Chair & CEO | 05 Jan 2024 | Sale | 18,198 | 10.6522 | 193,849 | D |
08 Jan 2024 18:14 | ZYME | Zymeworks Inc | ASTLE CHRISTOPHER | SVP & Chief Financial Officer | 05 Jan 2024 | Sale | 4,563 | 10.6522 | 48,606 | D |
08 Jan 2024 18:01 | ZYME | Zymeworks Inc | MOORE PAUL ANDREW | Chief Scientific Officer | 05 Jan 2024 | Sale | 7,460 | 10.6522 | 79,465 | D |
11 Dec 2023 20:00 | ZYME | Zymeworks Inc | ASTLE CHRISTOPHER | SVP & Chief Financial Officer | 11 Dec 2023 | Sale | 886 | 9.1301 | 8,089 | D |
21 Jun 2023 16:04 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | 10% | 16 Jun 2023 | Purchase | 3,350,000 | 8.12 | 27,202,000 | I |
30 Mar 2023 17:47 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | 10% | 28 Mar 2023 | Purchase | 200,000 | 8 | 1,600,000 | I |
14 Mar 2023 17:00 | ZYME | Zymeworks Inc | KLOMPAS NEIL A | President & COO | 10 Mar 2023 | Sale | 2,977 | 7.8259 | 23,298 | D |
23 Jan 2023 18:00 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | 10% | 20 Jan 2023 | Purchase | 163,400 | 9.8843 | 1,615,095 | I |
23 Jan 2023 18:00 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | 10% | 19 Jan 2023 | Purchase | 144,100 | 9.4909 | 1,367,639 | I |
18 Jan 2023 18:27 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | 10% | 18 Jan 2023 | Purchase | 203,000 | 9.9953 | 2,029,046 | I |
18 Jan 2023 18:27 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | 10% | 17 Jan 2023 | Purchase | 440,000 | 9.8042 | 4,313,848 | I |
18 Jan 2023 18:27 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | 10% | 13 Jan 2023 | Purchase | 342,100 | 9.806 | 3,354,633 | I |
12 Jan 2023 16:47 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | 10% | 11 Jan 2023 | Purchase | 106,300 | 7.8731 | 836,911 | I |
12 Jan 2023 16:47 | ZYME | Zymeworks Inc | ECOR1 CAPITAL, LLC | 10% | 10 Jan 2023 | Purchase | 920,000 | 7.6491 | 7,037,172 | I |
23 Dec 2022 20:00 | ZYME | Zymeworks Inc | ASTLE CHRISTOPHER | SVP & Chief Financial Officer | 12 Dec 2022 | Sale A | 887 | 6.01 | 5,331 | D |
14 Dec 2022 20:00 | ZYME | Zymeworks Inc | ASTLE CHRISTOPHER | SVP & Chief Financial Officer | 12 Dec 2022 | Sale | 887 | 6.01 | 5,331 | D |
23 Dec 2022 20:00 | ZYME | Zymeworks Inc | JOSEPHSON NEIL | Chief Medical Officer | 10 Nov 2022 | Sale A | 2,475 | 8.099 | 20,045 | D |
14 Nov 2022 21:41 | ZYME | Zymeworks Inc | JOSEPHSON NEIL | Chief Medical Officer | 10 Nov 2022 | Sale | 2,475 | 8.099 | 20,045 | D |
14 Nov 2022 21:00 | ZYME | Zymeworks BC Inc | JOSEPHSON NEIL | Chief Medical Officer | 10 Nov 2022 | Sale | 2,475 | 8.099 | 20,045 | D |
18 Oct 2022 06:07 | ZYME | Zymeworks Inc | REDMILE GROUP, LLC | 10% | 13 Oct 2022 | Purchase A | 30,481 | 5.0338 | 153,435 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)